Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide in Postprandial Hyperlipidemia
NCT00974272Phase 4Completed
- Sponsor
- Carl T. Hayden VA Medical Center
- Start
- Aug 2006
- Primary completion
- Nov 2008
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of exenatide in type 2 diabetes mellitus (T2DM), impaired glucose tolerance (IGT), sponsored by Carl T. Hayden VA Medical Center. Started Aug 2006; status: completed.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)impaired glucose tolerance (IGT)
Beyond the preview
Go deeper on NCT00974272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00974272.